ReviewFrontiers in oncology2022

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer.

Rodolfo Chicas-Sett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.